Results
1 -
9 of
9
(Click
here to explore results)
Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 13 Cobicistat and Ritonavir as Pharmacoenhancers for Antiviral Drugs . Lianhong Xu, Manoj C. Desai
, 2013
, Pages 451-481
Allosterism in Drug Discovery, CHAPTER 2 Identifying and Quantifying Allosteric Drug Function . Terry Kenakin
, 2017
, Pages 24-39
Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 15 Cyclic Peptides as Privileged Structures . Prabhakar Cherkupally, Suhas Ramesh, Yahya E. Jad, Thavendran Govender, Hendrik G. Kruger, Beatriz G. de la Torre, Fernando Albericio
, 2016
, Pages 398-438
Accounts in Drug Discovery: Case Studies in Medicinal Chemistry, Chapter 9 From HTS to Market: the Discovery and Development of Maraviroc, a CCR5 Antagonist for the Treatment of HIV . Chris Barber, David Pryde
, 2011
, Pages 183-214
Anti-Inflammatory Drug Discovery, CHAPTER 11 CCR1 . J. ROBERT MERRITT, ANNETTE GILCHRIST
, 2012
, Pages 329-349
Extracellular and Intracellular Signaling, Chapter 11 G Protein-Coupled Receptors: Conformational “Gatekeepers” of Transmembrane Signal Transduction and Diversification . Ravinder Abrol, William A. Goddard III, FRSC
, 2011
, Pages 188-229
G Protein-Coupled Receptors: From Structure to Function, Chapter 22 Functional Selectivity of Drugs for Seven Transmembrane Receptors: Biased Agonism and Antagonism . Terry Kenakin
, 2011
, Pages 429-445
Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 4 Primary, Secondary and Tertiary Amines and their Isosteres . D. K. Walker, R. M. Jones, A. N. R. Nedderman, P. A. Wright
, 2010
, Pages 168-209